Загрузка...
Belimumab in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is one of the most challenging autoimmune disorders with a complex pathophysiology and diverse clinical presentation. Many drugs have been used to treat SLE with suboptimal results, especially in patients with moderate-to-severe disease. Belimumab is the first biol...
Сохранить в:
| Опубликовано в: : | RMD Open |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4612697/ https://ncbi.nlm.nih.gov/pubmed/26509047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000011 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|